Current Controlled Trials - Search the ISRCTN Register of Clinical Trials.

Welcome

07 August 2008

	Trial registration
	Unique identification scheme
	International databases

Find trials

ISRCTN Register

Registration

New application

Updating record

Information

introduction

governing board

ISRCTN FAQs

data set

guidance notes

International Standard Randomised Controlled Trial Number Register

Showing records: 6611 to 6620 of 7036

SEARCH FOR	RESULTS ORDER	DIRECTION	MAX RESULTS

6611	A Study to Compare the Effect of Two Blinded Doses of Casodex (ICI 176,334 100 mg and 150 mg daily) and Castration in the Treatment of Advanced Carcinoma of the Prostate
	ISRCTN:	ISRCTN44967321
	Sponsor:	AstraZeneca Clinical Research Group (UK)
	Date assigned:	19 August 2002

6612	Comparison of Second-Line Hormonal Agents Medroxyprogesterone Acetate and Aminoglutethimide in Advanced Breast Cancer
	ISRCTN:	ISRCTN44725655
	Sponsor:	Ciba-Geigy Pharmaceuticals (Switzerland)
	Date assigned:	19 August 2002

6613	A Randomised study of continuous Infusional 5-Fluorouracil (5FU) with or without bolus Mitomycin-C in patients with advanced oesophago-gastric cancer
	ISRCTN:	ISRCTN43866427
	Sponsor:	Royal Marsden Hospital (UK)
	Date assigned:	19 August 2002

6614	A Randomised Pilot Study of Symptom-Driven versus Routine Follow-Up in Asymptomatic Breast Cancer Patients Receiving Regular Mammography
	ISRCTN:	ISRCTN43743674
	Sponsor:	International Collaborative Cancer Group (ICGG) (UK)
	Date assigned:	19 August 2002

6615	A randomised study comparing carboplatin and carboplatin with thalidomide in patients with Stage Ic-IV Ovarian Cancer
	ISRCTN:	ISRCTN12694440
	Sponsor:	Cancer Research UK (CRUK) (UK)
	Date assigned:	19 August 2002

6616	Interferon alpha in combination with thalidomide in the treatment of metastatic renal cell carcinoma - a randomised phase II study
	ISRCTN:	ISRCTN11978947
	Sponsor:	UK Co-ordinating Committee for Cancer Research (UKCCCR)
	Date assigned:	19 August 2002

6617	A randomised double-blind trial in post-menopausal women with primary breast cancer who have received adjuvant tamoxifen for 2-3 years, comparing subsequent adjuvant exemestane treatment with further tamoxifen
	ISRCTN:	ISRCTN11883920
	Sponsor:	Pharmacia Ltd (UK)
	Date assigned:	19 August 2002

6618	A Randomised Trial of Two Chemotherapy Regimens in the Treatment of Operable Osteosarcoma (Doxorubicin-Cisplatin versus Methotrexate-Vincristine-Doxorubicin plus Doxorubicin-Cisplatin plus Bleomycin-Cyclophosphamide-Dactinomycin)
	ISRCTN:	ISRCTN11824145
	Sponsor:	Medical Research Council (UK)
	Date assigned:	19 August 2002

6619	A Randomised Trial to Compare the Effects of Methotrexate and Vinblastine with Cisplatin, Methotrexate and Vinblastine in the Treatment of T4b, Locally Recurrent and Metastatic Transitional Cell Carcinoma
	ISRCTN:	ISRCTN11318989
	Sponsor:	Medical Research Council (UK)
	Date assigned:	19 August 2002

6620	International Study for the Salvage Treatment of Germ Cell Tumours
	ISRCTN:	ISRCTN11143611
	Sponsor:	Institut Gustave-Roussy (France)
	Date assigned:	19 August 2002

RESULT PAGE

662